Monday, December 22, 2014                

Find answers faster:

AOS Locations    

New Patient Forms

Research/Clinical Trials

AOS Physicians

 Call 602-274-4484 or 800-360-6371
or use our web request system

Next-day appointments on request.

Patient Comments
I'd like to thank you and your staff personally for taking my healthcare issues in your capable hands and hearts. I appreciate all you have done. Thank you from the bottom of my "cancer free"  heart. 
- Scottsdale Center patient

Very cheerful, helpful, and hopeful staff. Everyone was a delight...made the 6 weeks of radiation fly by... 
- Apache Junction Center patient

I never minded going to the clinic every day throughout my treatments because I felt the love and caring there. It was a serious event, but done in a professional manner. Thanks so much. 
- East Valley Center patient

Everyone was compassionate, concerned, and took wonderful care of me. All my problems were solved and all my questions answered. Great experience.
-Deer Valley Center patient

David G. Brachman, MD serves as the Medical Director of Radiation Oncology at St. Joseph's Hospital & Medical Center, Barrow Neurological Institute, in Phoenix, Arizona as well as at Arizona Oncology Services.  Dr. Brachman specializes in Stereotactic Radiosurgery (Gamma Knife & Peacock Fractionated) in addition to serving on the Skull Base Team at Barrow Neurological Institute. Additional areas of specialization include anal, rectal and colon carcinomas and head and neck cancer.

Prior to joining Arizona Oncology Services, Inc., Dr. Brachman taught both as an Instructor and Assistant Professor in the Department of Radiation and Cellular Oncology at the University of Chicago. He earned his medical degree at Loyola University of Chicago, Stritch School of Medicine, and completed a residency in Internal Medicine at Michael Reese University of Chicago before serving there as Associate Attending, Internal Medicine. Dr. Brachman then completed a second residency in Radiation Oncology at the Department of Radiation and Cellular Oncology, University of Chicago.

Dr. Brachman is board certified in both Internal Medicine by the American Board of Internal Medicine as well as Radiation Oncology by the American Board of Radiology and is a Professor at Barrow Neurological Institute.  Dr. Brachman is based at Barrow Neurological Institute/St. Joseph's Hospital and Medical Center.




2000 to present - prior archived.

Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.
Smith KA, Ashby LS, Gonzalez F, Brachman DG, Thomas T, Coons SW, Battaglia M, Scheck A.
J Neurosurg. 2008 Dec;109 Suppl:106-17. Erratum in: J Neurosurg. 2009 Jun;110(6):1323-4.
PMID: 19123896 [PubMed - indexed for MEDLINE]

A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ Jr, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP.
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):79-86. Epub 2007 Dec 31.
PMID: 18164847 [PubMed - indexed for MEDLINE]

Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ Jr, Robins HI, Brachman DG, Henderson RH, Mehta MP, Movsas B.
Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):71-8. Epub 2007 Dec 31.
PMID: 18164829 [PubMed - indexed for MEDLINE]

Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021.
Robins HI, Won M, Seiferheld WF, Schultz CJ, Choucair AK, Brachman DG, Demas WF, Mehta MP.
Neuro Oncol. 2006 Jan;8(1):47-52.
PMID: 16443947 [PubMed - indexed for MEDLINE]
Free article in PMC | at journal site

Ectopic intracavernous sinus adrenocorticotropic hormone-secreting microadenoma: could this be a common cause of failed transsphenoidal surgery in Cushing disease? Case report.
Kim LJ, Klopfenstein JD, Cheng M, Nagul M, Coons S, Fredenberg C, Brachman DG, White WL.
J Neurosurg. 2003 Jun;98(6):1312-7.
PMID: 12816280 [PubMed - indexed for MEDLINE]

Failure free survival following brachytherapy alone for prostate cancer: comparison with external beam radiotherapy.
Beyer DC, Brachman DG.
Radiother Oncol. 2000 Dec;57(3):263-7.

PMID: 11104883 [PubMed - indexed for MEDLINE]

Privacy Statement   |   Terms Of Use Copyright 2013 by Arizona Oncology Services